146 related articles for article (PubMed ID: 37986295)
1. Severe immediate hypersensitivity to gadolinium contrast agent after targeted treatment in a patient with alveolar soft part sarcoma: A case report and review of literature.
Yan H; Zhang J; Cai X; Hao Z; Guan Z
Medicine (Baltimore); 2023 Nov; 102(46):e36092. PubMed ID: 37986295
[TBL] [Abstract][Full Text] [Related]
2. Preventive Effect of Changing Contrast Media in Patients With A Prior Mild Immediate Hypersensitivity Reaction to Gadolinium-Based Contrast Agent.
Ryoo CH; Choi YH; Cheon JE; Yoon SH; Kang HR; Park SJ; Lee W
Invest Radiol; 2019 Oct; 54(10):633-637. PubMed ID: 31033674
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough Hypersensitivity Reactions to Gadolinium-based Contrast Agents and Strategies to Decrease Subsequent Reaction Rates: A Systematic Review and Meta-Analysis.
Walker DT; Davenport MS; McGrath TA; McInnes MDF; Shankar T; Schieda N
Radiology; 2020 Aug; 296(2):312-321. PubMed ID: 32427558
[TBL] [Abstract][Full Text] [Related]
4. Incidence of immediate gadolinium contrast media reactions.
Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of Immediate Reactions to Injectable Gadolinium-based Contrast Agents.
Carr TF
Top Magn Reson Imaging; 2016 Dec; 25(6):265-268. PubMed ID: 27748716
[TBL] [Abstract][Full Text] [Related]
6. Adverse allergic reactions to linear ionic gadolinium-based contrast agents: experience with 194, 400 injections.
Aran S; Shaqdan KW; Abujudeh HH
Clin Radiol; 2015 May; 70(5):466-75. PubMed ID: 25626627
[TBL] [Abstract][Full Text] [Related]
7. Immediate hypersensitivity reaction to gadolinium-based MR contrast media.
Jung JW; Kang HR; Kim MH; Lee W; Min KU; Han MH; Cho SH
Radiology; 2012 Aug; 264(2):414-22. PubMed ID: 22550309
[TBL] [Abstract][Full Text] [Related]
8. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
[TBL] [Abstract][Full Text] [Related]
9. Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents.
Hojreh A; Peyrl A; Bundalo A; Szepfalusi Z
PLoS One; 2020; 15(4):e0230781. PubMed ID: 32243440
[TBL] [Abstract][Full Text] [Related]
10. Empiric Switching of Gadolinium-Based Contrast Agents in Patients With History of Previous Immediate Hypersensitivity Reaction to GBCA: A Prospective Single-Center, Single-Arm Efficacy Trial.
Walker D; McGrath TA; Glikstein R; Chakraborty S; Blanchette C; Schieda N
Invest Radiol; 2021 Jun; 56(6):369-373. PubMed ID: 33337738
[TBL] [Abstract][Full Text] [Related]
11. Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis.
Behzadi AH; Zhao Y; Farooq Z; Prince MR
Radiology; 2018 Feb; 286(2):471-482. PubMed ID: 28846495
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity reactions to gadolinium-based contrast agents.
Fok JS; Smith WB
Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):241-246. PubMed ID: 28537933
[TBL] [Abstract][Full Text] [Related]
13. Insight into the dynamic of gadolinium based contrast agent (GBCA) hypersensitivity: Acquisition, persistence and disappearance.
Boehm I; Hungerbühler M; Heverhagen JT
Magn Reson Imaging; 2018 Jun; 49():1-3. PubMed ID: 29247752
[TBL] [Abstract][Full Text] [Related]
14. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
15. Acute Reactions to Gadolinium-Based Contrast Agents in a Pediatric Cohort: A Retrospective Study of 16,237 Injections.
McDonald JS; Larson NB; Kolbe AB; Hunt CH; Schmitz JJ; Kallmes DF; McDonald RJ
AJR Am J Roentgenol; 2021 May; 216(5):1363-1369. PubMed ID: 32755216
[No Abstract] [Full Text] [Related]
16. Preventing Allergic Reactions to Gadolinium-Based Contrast Agents.
Heshmatzadeh Behzadi A; Prince MR
Top Magn Reson Imaging; 2016 Dec; 25(6):275-279. PubMed ID: 27748715
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
[TBL] [Abstract][Full Text] [Related]
18. How to Manage (Treat) Immediate-type Adverse Reactions to GBCA.
Thomsen HS
Top Magn Reson Imaging; 2016 Dec; 25(6):269-274. PubMed ID: 27849654
[TBL] [Abstract][Full Text] [Related]
19. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
[TBL] [Abstract][Full Text] [Related]
20. Clinical validation of the basophil activation test in immediate hypersensitivity reactions to gadolinium-based contrast agents.
Cabrera CM; Clarcast M; Palacios-Cañas A
Int Immunopharmacol; 2023 Apr; 117():110000. PubMed ID: 37012878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
